Covidien Launches NeoMode Software Upgrade for Puritan Bennett 840 Ventilator
* Reuters is not responsible for the content in this press release.
Latest Covidien Innovation Aids Respiratory Care for Newborns BOULDER, Colo.--(Business Wire)-- Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the worldwide launch of the NeoMode software upgrade for thePuritan Bennett 840ventilator, an improvement designed to help clinicians better manage neonate patients. The NeoMode software upgrade enables clinical staff to increase set FiO2 by 20 percent for a period of up to two minutes. It also features noninvasive, neonatal continuous positive airway pressure (CPAP), which can reduce nuisance alarms when patients are breathing noninvasively. Additionally, as neonates grow, the required base-level software upgrade enables clinicians to easily adjust the ideal body weight (IBW) setting without disconnecting the patient or power-cycling the ventilator. Innovation that enhances patient safety and life support is critical. With this in mind, Covidien developed the NeoMode software upgrade through collaboration with practitioners who provided insight on which ventilator features were most critical for neonate patients. "These enhancements are aimed at helping clinicians more effectively manage neonates and premature infants," said Douglas M. Hansell, M.D., Chief Medical Officer and Vice President, Respiratory and Monitoring Solutions, Covidien. "Being able to easily adjust the ventilator when neonates grow rapidly will naturally facilitate care, as well as maintain the appropriate levels of oxygen. In addition, the reduction in nuisance alarms will help the clinical staff be more efficient." "Covidien is committed to developing healthcare solutions that meet the highest standards of medical efficacy," said Jim Willett, Vice President and General Manager, Ventilation and Airway, Respiratory and Monitoring Solutions, Covidien. "This software upgrade reflects our ongoing commitment to innovation and to enhancing the functionality, reliability and accuracy of all our respiratory care tools." About Covidien Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. Covidien Sherri Hughes-Smith, 303-581-6849 Manager, Media and Public Relations Respiratory and Monitoring Solutions sherri.hughes-smith@covidien.com or Bruce Farmer, 508-452-4372 Vice President Public Relations bruce.farmer@covidien.com or Coleman Lannum, CFA, 508-421-4343 Vice President Investor Relations cole.lannum@covidien.com or Brian Nameth, 508-421-4363 Director Investor Relations brian.nameth@covidien.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters